Soroya M Rahaman, MD - Medicare Gastroenterology in Plymouth, MA

Soroya M Rahaman, MD is a medicare enrolled "Internal Medicine - Gastroenterology" physician in Plymouth, Massachusetts. She graduated from medical school in 1986 and has 38 years of diverse experience with area of expertise as Gastroenterology. She is a member of the group practice Jordan Physician Associates Inc and her current practice location is 47 Obery St, Plymouth, Massachusetts. You can reach out to her office (for appointments etc.) via phone at (508) 747-1560.

Soroya M Rahaman is licensed to practice in Massachusetts (license number 75477) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1669448049.

Contact Information

Soroya M Rahaman, MD
47 Obery St,
Plymouth, MA 02360-2229
(508) 747-1560
(508) 747-5155



Physician's Profile

Full NameSoroya M Rahaman
GenderFemale
SpecialityGastroenterology
Experience38 Years
Location47 Obery St, Plymouth, Massachusetts
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Soroya M Rahaman graduated from medical school in 1986
  NPI Data:
  • NPI Number: 1669448049
  • Provider Enumeration Date: 02/27/2006
  • Last Update Date: 11/09/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 7810964129
  • Enrollment ID: I20050503001184

Medical Identifiers

Medical identifiers for Soroya M Rahaman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1669448049NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RG0100XInternal Medicine - Gastroenterology ME148356 (Florida)Secondary
207RG0100XInternal Medicine - Gastroenterology 75477 (Massachusetts)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Beth Israel Deaconess Hospital PlymouthPlymouth, MAHospital
Tufts Medical CenterBoston, MAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Jordan Physician Associates Inc1254321086153

News Archive

Specific organometallic substances offer new hope for treatment against tapeworm infection

Scientists are reporting development and testing of a new series of drugs that could finally stop the fox tapeworm - which causes a rare but life-threatening disease in humans - dead in its tracks. The report, which appears in ACS' Journal of Medicinal Chemistry, shows that specific organometallic substances that help combat cancer are also the surprising best new hope for a treatment against tapeworm infection.

International community urged to disburse pledged funds to help Yemen

"The international community has been urged to follow Saudi Arabia's example by releasing funds pledged to help Yemen address its growing humanitarian crisis and economic, social and security challenges," the Guardian reports.

3D structures of nicotine receptor could lead to new ways for treating addiction

UT Southwestern researchers today published in Nature atomic-scale blueprints of the most abundant class of brain nicotinic acetylcholine receptors. A structural understanding of the protein, found in neurons, could lead to new ways to treat nicotine addiction from smoking and vaping.

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Soroya M Rahaman allows following entities to bill medicare on her behalf.
Entity NameJordan Physician Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1538145131
PECOS PAC ID: 1254321086
Enrollment ID: O20040514000167

News Archive

Specific organometallic substances offer new hope for treatment against tapeworm infection

Scientists are reporting development and testing of a new series of drugs that could finally stop the fox tapeworm - which causes a rare but life-threatening disease in humans - dead in its tracks. The report, which appears in ACS' Journal of Medicinal Chemistry, shows that specific organometallic substances that help combat cancer are also the surprising best new hope for a treatment against tapeworm infection.

International community urged to disburse pledged funds to help Yemen

"The international community has been urged to follow Saudi Arabia's example by releasing funds pledged to help Yemen address its growing humanitarian crisis and economic, social and security challenges," the Guardian reports.

3D structures of nicotine receptor could lead to new ways for treating addiction

UT Southwestern researchers today published in Nature atomic-scale blueprints of the most abundant class of brain nicotinic acetylcholine receptors. A structural understanding of the protein, found in neurons, could lead to new ways to treat nicotine addiction from smoking and vaping.

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.

Read more Medical News

› Verified 3 days ago

Entity NamePratt Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1275570319
PECOS PAC ID: 3375515661
Enrollment ID: O20040807000255

News Archive

Specific organometallic substances offer new hope for treatment against tapeworm infection

Scientists are reporting development and testing of a new series of drugs that could finally stop the fox tapeworm - which causes a rare but life-threatening disease in humans - dead in its tracks. The report, which appears in ACS' Journal of Medicinal Chemistry, shows that specific organometallic substances that help combat cancer are also the surprising best new hope for a treatment against tapeworm infection.

International community urged to disburse pledged funds to help Yemen

"The international community has been urged to follow Saudi Arabia's example by releasing funds pledged to help Yemen address its growing humanitarian crisis and economic, social and security challenges," the Guardian reports.

3D structures of nicotine receptor could lead to new ways for treating addiction

UT Southwestern researchers today published in Nature atomic-scale blueprints of the most abundant class of brain nicotinic acetylcholine receptors. A structural understanding of the protein, found in neurons, could lead to new ways to treat nicotine addiction from smoking and vaping.

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.

Read more Medical News

› Verified 3 days ago

Entity NameSteward Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1629398219
PECOS PAC ID: 2860688728
Enrollment ID: O20101119000332

News Archive

Specific organometallic substances offer new hope for treatment against tapeworm infection

Scientists are reporting development and testing of a new series of drugs that could finally stop the fox tapeworm - which causes a rare but life-threatening disease in humans - dead in its tracks. The report, which appears in ACS' Journal of Medicinal Chemistry, shows that specific organometallic substances that help combat cancer are also the surprising best new hope for a treatment against tapeworm infection.

International community urged to disburse pledged funds to help Yemen

"The international community has been urged to follow Saudi Arabia's example by releasing funds pledged to help Yemen address its growing humanitarian crisis and economic, social and security challenges," the Guardian reports.

3D structures of nicotine receptor could lead to new ways for treating addiction

UT Southwestern researchers today published in Nature atomic-scale blueprints of the most abundant class of brain nicotinic acetylcholine receptors. A structural understanding of the protein, found in neurons, could lead to new ways to treat nicotine addiction from smoking and vaping.

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Soroya M Rahaman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Soroya M Rahaman, MD
47 Obery St,
Plymouth, MA 02360-2229

Ph: (508) 747-1560
Soroya M Rahaman, MD
47 Obery St,
Plymouth, MA 02360-2229

Ph: (508) 747-1560

News Archive

Specific organometallic substances offer new hope for treatment against tapeworm infection

Scientists are reporting development and testing of a new series of drugs that could finally stop the fox tapeworm - which causes a rare but life-threatening disease in humans - dead in its tracks. The report, which appears in ACS' Journal of Medicinal Chemistry, shows that specific organometallic substances that help combat cancer are also the surprising best new hope for a treatment against tapeworm infection.

International community urged to disburse pledged funds to help Yemen

"The international community has been urged to follow Saudi Arabia's example by releasing funds pledged to help Yemen address its growing humanitarian crisis and economic, social and security challenges," the Guardian reports.

3D structures of nicotine receptor could lead to new ways for treating addiction

UT Southwestern researchers today published in Nature atomic-scale blueprints of the most abundant class of brain nicotinic acetylcholine receptors. A structural understanding of the protein, found in neurons, could lead to new ways to treat nicotine addiction from smoking and vaping.

Erbitux-based therapy helps in early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.

Read more News

› Verified 3 days ago


Internal Medicine Doctors in Plymouth, MA

Gregory Joseph Robke, MD
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 45 Resnik Road, Suite 302, Plymouth, MA 02360
Phone: 508-746-2696    Fax: 508-746-2695
Dr. Irina Gurevich, M.D.
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 275 Sandwich St, C/o Cathy Grey, Plymouth, MA 02360
Phone: 508-830-2390    Fax: 508-830-2399
Maysaa El Zoghbi, M.D.
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 275 Sandwich St, Plymouth, MA 02360
Phone: 508-746-2000    
Baigalmaa Enkhtaivan,
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 275 Sandwich St, Plymouth, MA 02360
Phone: 508-830-2679    Fax: 508-830-2702
Senada Arabelovic, DO
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 45 Resnik Rd, Plymouth, MA 02360
Phone: 508-746-5351    
Muhammad Mubarak, M.D.
Gastroenterology
Medicare: Medicare Enrolled
Practice Location: 275 Sandwich St, Plymouth, MA 02360
Phone: 617-754-4677    
Katherine Murray Leisure, MD
Gastroenterology
Medicare: Accepting Medicare Assignments
Practice Location: 116 Court St, 3rd Floor, Plymouth, MA 02360
Phone: 508-746-2138    Fax: 508-746-2148

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.